Pharmacokinetics and Osteogenic Potential of PEGylated NELL-1 In Vivo After Systemic Administration

Osteoporosis is a skeletal disorder attributable to an imbalance in osteoblast and osteoclast activity. NELL-1, a secretory protein that promotes osteogenesis while suppressing osteoclastic activity, holds potential as an osteoporosis therapy. Recently, we demonstrated that PEGylation of NELL-1 sign...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biomaterials
Hlavní autoři: Kwak, Jin Hee, Zhang, Yulong, Park, Juyoung, Chen, Eric, Shen, Jia, Chawan, Chirag, Tanjaya, Justine, Lee, Soonchul, Zhang, Xinli, Wu, Benjamin, Ting, Kang, Soo, Chia
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4426150/
https://ncbi.nlm.nih.gov/pubmed/25913252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2015.03.063
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky